Tute Genomics, a Provo, Utah-based provider of cloud solutions for genome analysis, raised $2.3m in Series A1 funding.
The round was led by UK-based Eurovestech with participation from Peak Ventures and a number of angel investors.
The company intends to use the funds to expedite genetic discoveries and enable the adoption of genomic medicine in everyday clinical care.
Led by Reid Robison, MD MBA, and CEO, and Kai Wang, PhD, President, Tute Genomics has developed a comprehensive cloud-based genome analytics platform for clinicians and researchers to draw meaningful insights from genome sequencing data. Nearly 10,000 samples have already been processed by the platform, while the company has commercial agreements in place across numerous institutions including clinical labs, molecular diagnostic companies, and research institutions.
FinSMEs
05/12/2014